BamSEC and AlphaSense Join Forces
Learn More

Opus Genetics Inc.

NASDAQ: IRD    
Share price (10/21/25): $2.01    
Market cap (10/21/25): $120 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.8
from S-8 1 page Fourth Amendment to Ocuphire Pharma, Inc. 2021 Inducement Plan
12/34/56
EX-4.7
from S-8 1 page Third Amendment to Ocuphire Pharma, Inc. 2021 Inducement Plan
12/34/56
EX-4.12
from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.2
from 8-K 20 pages Pre-Funded Common Stock Purchase Warrant Opus Genetics, Inc
12/34/56
EX-4.1
from 8-K 24 pages Common Stock Purchase Warrant Opus Genetics, Inc
12/34/56
EX-4.6
from S-8 1 page Second Amendment to Ocuphire Pharma, Inc. 2021 Inducement Plan
12/34/56
EX-4.17
from S-3 17 pages Ocuphire Pharma, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of Ocuphire Pharma, Inc. Form of Debt Securities Warrant Agreement
12/34/56
EX-4.16
from S-3 18 pages Ocuphire Pharma, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of Ocuphire Pharma, Inc. Form of Preferred Stock Warrant Agreement
12/34/56
EX-4.15
from S-3 18 pages Agreement
12/34/56
EX-4.13
from S-3 41 pages Ocuphire Pharma, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [●], 20 Debt Securities
12/34/56
EX-4.1
from 8-K/A 18 pages Common Stock Purchase Warrant Ocuphire Pharma, Inc
12/34/56
EX-4.1
from 8-K 18 pages Common Stock Purchase Warrant Ocuphire Pharma, Inc
12/34/56
EX-4.11
from 10-K 3 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.7
from S-3 20 pages Ocuphire Pharma, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of Ocuphire Pharma, Inc. Form of Debt Securities Warrant Agreement
12/34/56
EX-4.6
from S-3 23 pages Ocuphire Pharma, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of Ocuphire Pharma, Inc. Form of Preferred Stock Warrant Agreement
12/34/56
EX-4.5
from S-3 22 pages Ocuphire Pharma, Inc. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as of Ocuphire Pharma, Inc. Form of Common Stock Warrant Agreement
12/34/56
EX-4.3
from S-3 42 pages Ocuphire Pharma, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [●], 20 Debt Securities
12/34/56
EX-4.1
from 8-K 27 pages Waiver Agreement
12/34/56
EX-4.9
from S-4 26 pages Stockholders Agreement of Ocuphire Pharma, Inc. Dated Effective as of April 10, 2018
12/34/56
EX-4.1
from 425 34 pages [Form of Series [A] [B] Warrant]
12/34/56